Last reviewed · How we verify

NCT07030686

Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors

Recruiting now Last updated 9 January 2026
What this trial tests

trial testing Exercise in Survivorship in 1,000 participants. Currently enrolling.

Timeline
19 March 2020
Primary endpoint
19 March 2026
19 March 2026

Quick facts

Lead sponsorMemorial Sloan Kettering Cancer Center
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment1,000
Start date19 March 2020
Primary completion19 March 2026
Estimated completion19 March 2026
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Memorial Sloan Kettering Cancer Center — full company profile →

Who can join

18 and older, any sex, with Survivorship or Recurrent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This protocol is a retrospective study using observational data to conduct a target trial emulation to examine the association of exercise on cancer specific endpoints and other clinical outcomes in cancer survivors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Survivorship

Currently open trials in the same condition.

Other Memorial Sloan Kettering Cancer Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07030686.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing